A Case Report of Turner Syndrome with Graves’ Disease during Recombinant Human GH Therapy and Review of Literature
Identifieur interne : 006628 ( Ncbi/Merge ); précédent : 006627; suivant : 006629A Case Report of Turner Syndrome with Graves’ Disease during Recombinant Human GH Therapy and Review of Literature
Auteurs : Makio Nakagawa ; Yasuji Inamo ; Kensuke HaradaSource :
- Clinical Pediatric Endocrinology [ 0918-5739 ] ; 2006.
Abstract
An increased incidence of Hashimoto thyroiditis has been reported in patients with Turner syndrome, but several cases of Graves’ disease were also described ten to 20 years ago. We report the case of a patient with Turner syndrome who developed Graves’ disease, 3 years after successful treatment with recombinant human growth hormone (GH). A diagnosis of Graves’ disease was made and treatment with thiamazole was started, which resulted in normalization of the thyroid function. It is important to monitor thyroid function as well as growth parameters in patients with Turner syndrome.
Url:
DOI: 10.1297/cpe.15.55
PubMed: 24790321
PubMed Central: 4004847
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 003D55
- to stream Pmc, to step Curation: 003D54
- to stream Pmc, to step Checkpoint: 003D07
Links to Exploration step
PMC:4004847Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A Case Report of Turner Syndrome with Graves’ Disease during Recombinant
Human GH Therapy and Review of Literature</title><author><name sortKey="Nakagawa, Makio" sort="Nakagawa, Makio" uniqKey="Nakagawa M" first="Makio" last="Nakagawa">Makio Nakagawa</name></author><author><name sortKey="Inamo, Yasuji" sort="Inamo, Yasuji" uniqKey="Inamo Y" first="Yasuji" last="Inamo">Yasuji Inamo</name></author><author><name sortKey="Harada, Kensuke" sort="Harada, Kensuke" uniqKey="Harada K" first="Kensuke" last="Harada">Kensuke Harada</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">24790321</idno><idno type="pmc">4004847</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004847</idno><idno type="RBID">PMC:4004847</idno><idno type="doi">10.1297/cpe.15.55</idno><date when="2006">2006</date><idno type="wicri:Area/Pmc/Corpus">003D55</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003D55</idno><idno type="wicri:Area/Pmc/Curation">003D54</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003D54</idno><idno type="wicri:Area/Pmc/Checkpoint">003D07</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003D07</idno><idno type="wicri:Area/Ncbi/Merge">006628</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">A Case Report of Turner Syndrome with Graves’ Disease during Recombinant
Human GH Therapy and Review of Literature</title><author><name sortKey="Nakagawa, Makio" sort="Nakagawa, Makio" uniqKey="Nakagawa M" first="Makio" last="Nakagawa">Makio Nakagawa</name></author><author><name sortKey="Inamo, Yasuji" sort="Inamo, Yasuji" uniqKey="Inamo Y" first="Yasuji" last="Inamo">Yasuji Inamo</name></author><author><name sortKey="Harada, Kensuke" sort="Harada, Kensuke" uniqKey="Harada K" first="Kensuke" last="Harada">Kensuke Harada</name></author></analytic><series><title level="j">Clinical Pediatric Endocrinology</title><idno type="ISSN">0918-5739</idno><idno type="eISSN">1347-7358</idno><imprint><date when="2006">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p> An increased incidence of Hashimoto thyroiditis has been reported in patients with
Turner syndrome, but several cases of Graves’ disease were also described ten to 20 years
ago. We report the case of a patient with Turner syndrome who developed Graves’ disease,
3 years after successful treatment with recombinant human growth hormone (GH). A diagnosis
of Graves’ disease was made and treatment with thiamazole was started, which resulted in
normalization of the thyroid function. It is important to monitor thyroid function as well
as growth parameters in patients with Turner syndrome.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Mchardy Young, S" uniqKey="Mchardy Young S">S McHardy-Young</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chang, Jc" uniqKey="Chang J">JC Chang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Brooks, Wh" uniqKey="Brooks W">WH Brooks</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kawai, K" uniqKey="Kawai K">K Kawai</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Marcocci, C" uniqKey="Marcocci C">C Marcocci</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Massa, G" uniqKey="Massa G">G Massa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chiovato, L" uniqKey="Chiovato L">L Chiovato</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sakurai, T" uniqKey="Sakurai T">T Sakurai</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Higashino, H" uniqKey="Higashino H">H Higashino</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Murashita, M" uniqKey="Murashita M">M Murashita</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Okada, Y" uniqKey="Okada Y">Y Okada</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Niimi, H" uniqKey="Niimi H">H Niimi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Davies, Tf" uniqKey="Davies T">TF Davies</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sybert, Vp" uniqKey="Sybert V">VP Sybert</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Pediatr Endocrinol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Pediatr Endocrinol</journal-id><journal-id journal-id-type="publisher-id">CPE</journal-id><journal-title-group><journal-title>Clinical Pediatric Endocrinology</journal-title></journal-title-group><issn pub-type="ppub">0918-5739</issn><issn pub-type="epub">1347-7358</issn><publisher><publisher-name>The Japanese Society for Pediatric Endocrinology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24790321</article-id><article-id pub-id-type="pmc">4004847</article-id><article-id pub-id-type="publisher-id">15-055</article-id><article-id pub-id-type="doi">10.1297/cpe.15.55</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>A Case Report of Turner Syndrome with Graves’ Disease during Recombinant
Human GH Therapy and Review of Literature</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nakagawa</surname><given-names>Makio</given-names></name></contrib><contrib contrib-type="author"><name><surname>Inamo</surname><given-names>Yasuji</given-names></name></contrib><contrib contrib-type="author"><name><surname>Harada</surname><given-names>Kensuke</given-names></name></contrib><aff id="aff1">Department of General Pediatrics, Nerima-Hikarigaoka Nihon University Hospital, Nihon University School of Medicine, Tokyo, Japan</aff></contrib-group><author-notes><corresp id="cor">Correspondence: Dr. Yasuji Inamo, Department of General Pediatrics,
Nerima-Hikarigaoka Nihon University Hospital, Nihon University School of Medicine, 2-11-1,
Hikarigaoka, Nerima-ku, Tokyo 179-0072, Japan. E-mail: <email xlink:href="y-inamo@pb3.so-net.ne.jp">y-inamo@pb3.so-net.ne.jp</email></corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>4</month><year>2006</year></pub-date><pub-date pub-type="ppub"><year>2006</year></pub-date><volume>15</volume><issue>2</issue><fpage>55</fpage><lpage>59</lpage><history><date date-type="received"><day>01</day><month>9</month><year>2005</year></date><date date-type="accepted"><day>12</day><month>1</month><year>2006</year></date></history><permissions><copyright-statement>2006©The Japanese Society for Pediatric
Endocrinology</copyright-statement><copyright-year>2006</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p> An increased incidence of Hashimoto thyroiditis has been reported in patients with
Turner syndrome, but several cases of Graves’ disease were also described ten to 20 years
ago. We report the case of a patient with Turner syndrome who developed Graves’ disease,
3 years after successful treatment with recombinant human growth hormone (GH). A diagnosis
of Graves’ disease was made and treatment with thiamazole was started, which resulted in
normalization of the thyroid function. It is important to monitor thyroid function as well
as growth parameters in patients with Turner syndrome.</p></abstract><kwd-group><kwd>Turner syndrome</kwd><kwd>Graves’ disease</kwd><kwd>hyperthyroidism</kwd><kwd>recombinant human growth hormone therapy</kwd></kwd-group></article-meta></front></pmc><affiliations><list></list><tree><noCountry><name sortKey="Harada, Kensuke" sort="Harada, Kensuke" uniqKey="Harada K" first="Kensuke" last="Harada">Kensuke Harada</name><name sortKey="Inamo, Yasuji" sort="Inamo, Yasuji" uniqKey="Inamo Y" first="Yasuji" last="Inamo">Yasuji Inamo</name><name sortKey="Nakagawa, Makio" sort="Nakagawa, Makio" uniqKey="Nakagawa M" first="Makio" last="Nakagawa">Makio Nakagawa</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006628 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 006628 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= PMC:4004847
|texte= A Case Report of Turner Syndrome with Graves’ Disease during Recombinant
Human GH Therapy and Review of Literature
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:24790321" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |